BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24389236)

  • 1. Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection.
    Anders M; Bähr C; El-Masry MA; Marx AH; Koch M; Seewald S; Schachschal G; Adler A; Soehendra N; Izbicki J; Neuhaus P; Pohl H; Rösch T
    Gut; 2014 Oct; 63(10):1535-43. PubMed ID: 24389236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
    Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
    Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
    Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
    Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.
    Pouw RE; Seewald S; Gondrie JJ; Deprez PH; Piessevaux H; Pohl H; Rösch T; Soehendra N; Bergman JJ
    Gut; 2010 Sep; 59(9):1169-77. PubMed ID: 20525701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia.
    Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ
    Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
    Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
    Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic Barrett's oesophagus and long-term follow-up after endoscopic therapy: complete histological eradication of Barrett associated with high-grade dysplasia significantly decreases neoplasia relapse.
    Caillol F; Godat S; Autret A; Bories E; Pesenti C; Ratone JP; Poizat F; Guiramand J; Delpero JR; Giovannini M
    Surg Endosc; 2016 Dec; 30(12):5410-5418. PubMed ID: 27129553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.
    Giovannini M; Bories E; Pesenti C; Moutardier V; Monges G; Danisi C; Lelong B; Delpero JR
    Endoscopy; 2004 Sep; 36(9):782-7. PubMed ID: 15326573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
    Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
    Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.
    Pouw RE; Peters FP; Sempoux C; Piessevaux H; Deprez PH
    Endoscopy; 2008 Nov; 40(11):892-8. PubMed ID: 19009481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Schoon EJ; Weusten BL; Bergman JJ
    Endoscopy; 2012 Dec; 44(12):1096-104. PubMed ID: 23108809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia.
    Terheggen G; Horn EM; Vieth M; Gabbert H; Enderle M; Neugebauer A; Schumacher B; Neuhaus H
    Gut; 2017 May; 66(5):783-793. PubMed ID: 26801885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
    Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
    Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett's esophagus.
    Canto MI; Shin EJ; Khashab MA; Molena D; Okolo P; Montgomery E; Pasricha P
    Endoscopy; 2015 Jul; 47(7):582-91. PubMed ID: 25826275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.